Search by Drug Name or NDC

    NDC 25021-0675-10 Methocarbamol 100 mg/mL Details

    Methocarbamol 100 mg/mL

    Methocarbamol is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is METHOCARBAMOL.

    Product Information

    NDC 25021-0675
    Product ID 25021-675_5b7bad7e-ec8a-4e45-8379-b1229a679030
    Associated GPIs 75100070002010
    GCN Sequence Number 004653
    GCN Sequence Number Description methocarbamol VIAL 100 MG/ML INJECTION
    HIC3 H6H
    HIC3 Description SKELETAL MUSCLE RELAXANTS
    GCN 17881
    HICL Sequence Number 001938
    HICL Sequence Number Description METHOCARBAMOL
    Brand/Generic Generic
    Proprietary Name Methocarbamol
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methocarbamol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name METHOCARBAMOL
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205404
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0675-10 (25021067510)

    NDC Package Code 25021-675-10
    Billing NDC 25021067510
    Package 25 VIAL in 1 CARTON (25021-675-10) / 10 mL in 1 VIAL
    Marketing Start Date 2018-02-15
    NDC Exclude Flag N
    Pricing Information N/A